
Citius Oncology Signs Distribution Deal with Cardinal Health
Agreement supports the upcoming launch of LYMPHIR for the treatment of cutaneous T-cell lymphoma Citius Oncology, Inc., the oncology-focused subsidiary of Citius Pharmaceuticals, Inc, a
Agreement supports the upcoming launch of LYMPHIR for the treatment of cutaneous T-cell lymphoma Citius Oncology, Inc., the oncology-focused subsidiary of Citius Pharmaceuticals, Inc, a
Kendall DL Multi System simplifies patient monitoring, drives efficiencies for providers Cardinal Health announced the U.S. launch of its multi-parameter, single-patient use monitoring cable and
ColorTokens, a global leader in enterprise microsegmentation, announced the appointment of Dr. Guru Gurushankar as Senior Vice President and General Manager for the Healthcare and
Fuel up with free Health Tech Insights